These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24001777)

  • 1. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer.
    Zou Y; Wang F; Liu FY; Huang MZ; Li W; Yuan XQ; Huang OP; He M
    Gene; 2013 Nov; 531(1):112-6. PubMed ID: 24001777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas.
    Sakamoto H; Kuboki Y; Hatori T; Yamamoto M; Sugiyama M; Shibata N; Shimizu K; Shiratori K; Furukawa T
    Mod Pathol; 2015 Feb; 28(2):261-7. PubMed ID: 25081753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of
    Zou Y; Huang MZ; Liu FY; Yang BC; Wang LQ; Wang F; Yu XH; Wan L; Wan XD; Xu XY; Li W; Huang OP; He M
    Biomed Rep; 2015 Jan; 3(1):33-37. PubMed ID: 25469243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.
    Ryland GL; Hunter SM; Doyle MA; Rowley SM; Christie M; Allan PE; Bowtell DD; ; Gorringe KL; Campbell IG
    J Pathol; 2013 Feb; 229(3):469-76. PubMed ID: 23096461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma.
    Zou Y; Liu FY; Liu H; Wang F; Li W; Huang MZ; Huang Y; Yuan XQ; Xu XY; Huang OP; He M
    Mutat Res; 2014 Mar; 761():49-52. PubMed ID: 24472300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel somatic MAPK1 mutation in primary ovarian mixed germ cell tumors.
    Zou Y; Deng W; Wang F; Yu XH; Liu FY; Yang BC; Huang MZ; Guo JB; Xie QH; He M; Huang OP
    Oncol Rep; 2016 Feb; 35(2):725-30. PubMed ID: 26548627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer.
    Wang F; Zou Y; Liu FY; Yu XH; Huang H; Zhang N; Qi YY; Liu RF; Liu XY; Chen J; Huang OP; He M
    Mol Med Rep; 2013 Jun; 7(6):1826-30. PubMed ID: 23588898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas.
    Shih IeM; Panuganti PK; Kuo KT; Mao TL; Kuhn E; Jones S; Velculescu VE; Kurman RJ; Wang TL
    Am J Pathol; 2011 Apr; 178(4):1442-7. PubMed ID: 21435433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
    Gemignani ML; Schlaerth AC; Bogomolniy F; Barakat RR; Lin O; Soslow R; Venkatraman E; Boyd J
    Gynecol Oncol; 2003 Aug; 90(2):378-81. PubMed ID: 12893203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
    Wu J; Jiao Y; Dal Molin M; Maitra A; de Wilde RF; Wood LD; Eshleman JR; Goggins MG; Wolfgang CL; Canto MI; Schulick RD; Edil BH; Choti MA; Adsay V; Klimstra DS; Offerhaus GJ; Klein AP; Kopelovich L; Carter H; Karchin R; Allen PJ; Schmidt CM; Naito Y; Diaz LA; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B
    Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21188-93. PubMed ID: 22158988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF43 is frequently mutated in colorectal and endometrial cancers.
    Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
    Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
    Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
    Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ
    Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of 103 ovarian serous and mucinous tumors.
    Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
    Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.